Engineers Gate Manager LP Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $271,056 - $284,782	1,870 Added 110.91%	3,556 $538,000
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $1.86 Million - $3.27 Million	-22,403 Reduced 93.0%	1,686 $246,000
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $2.65 Million - $3.44 Million	24,089 New	24,089 $2.86 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $274,955 - $409,359	-2,757 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $272,529 - $382,974	2,757 New	2,757 $383,000
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $934,076 - $1.49 Million	-14,200 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$64.07 - $91.75 $30,753 - $44,040	480 Added 3.5%	14,200 $971,000
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $892,760 - $1.35 Million	13,720 New	13,720 $1.18 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.